Skip to main content

Table 4 Multivariate analysis of disease free survival among patients with baseline BMI ≥ 23 kg/m2 (N = 338)

From: Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients

  

Adjusted HR (95 % CI)

p-value

Body weight change

Gain ≥ 5 kg

2.04 (1.02–4.08)

0.043

Others

1

 

Angiolymphatic invasion

Present

2.61 (1.37–4.94)

0.003

Absent

1

 

Perineural invasion

Present

2.51 (1.43–4.38)

0.001

Absent

1

 

T stage

T 4

1.99 (1.05–3.76)

0.035

T 1–3

1

 

N stage

N 2

2.34 (1.35–4.06)

0.002

N 0–1

1

 
  1. Abbreviations: HR hazard ratio, CI confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us